The proto-oncometabolite fumarate binds glutathione to amplify ROS-dependent signaling

Lucas B Sullivan1, Eva Martinez-Garcia, Hien Nguyen

  • 1Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

Molecular Cell
|June 11, 2013
PubMed

Insights

Fumarate hydratase (FH) loss in cancer cells increases fumarate, which depletes glutathione. This leads to reactive oxygen species (ROS) accumulation and activates HIF-1, promoting tumor growth.

Area of Science:

  • Biochemistry
  • Oncology
  • Cell Biology

Background:

  • Fumarate hydratase (FH) is a tumor suppressor in renal cell carcinoma.
  • FH-deficient cancer cells exhibit elevated fumarate, reactive oxygen species (ROS), and HIF-1 activation.
  • Mechanisms linking FH loss to increased ROS and HIF-1 are unclear.

Purpose of the Study:

  • Investigate how FH loss leads to increased fumarate, ROS, and HIF-1 activation.
  • Elucidate the role of glutamine metabolism in this process.
  • Identify fumarate's molecular targets and downstream effects.

Main Methods:

  • Utilized human FH-deficient cancer cells.
  • Analyzed glutamine-dependent oxidative citric acid cycle metabolism.
  • Performed in vitro and in vivo experiments to study fumarate-glutathione interactions.
  • Assessed NADPH levels, mitochondrial ROS, and histone methylation.

Main Results:

  • Glutamine metabolism fuels fumarate production, increasing ROS and HIF-1.
  • Accumulated fumarate binds glutathione, forming succinated glutathione (GSF).
  • GSF impairs glutathione reductase, reducing NADPH and boosting mitochondrial ROS.
  • Elevated ROS correlates with histone hypermethylation.

Conclusions:

  • Fumarate acts as a proto-oncometabolite by depleting glutathione.
  • This mechanism drives ROS accumulation and HIF-1 activation in FH-deficient cancers.
  • FH loss promotes a pro-tumorigenic environment through metabolic alterations.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Sulfur Assimilation01:20

Sulfur Assimilation

Sulfur is an essential element in biological systems, contributing to synthesizing key biomolecules, including amino acids such as cysteine and methionine, and cofactors such as coenzyme A and biotin. Microorganisms primarily assimilate sulfur as sulfate (SO₄²⁻) from the environment, which must undergo a series of biochemical transformations before it can be incorporated into cellular components. As sulfate is highly oxidized, it must undergo assimilatory sulfate reduction to become...